The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| INAB | -76.8% | N/A | N/A | -99% |
| S&P | +19.89% | +109.18% | +15.89% | +56% |
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | -$0.50M | 21.1% |
| Market Cap | $7.20M | -80.4% |
| Market Cap / Employee | $0.40M | -62.9% |
| Employees | 18 | 0.0% |
| Net Income | -$5.09M | 41.0% |
| EBITDA | -$4.70M | 41.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $13.23M | 29.5% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.18M | -47.1% |
| Short Term Debt | $0.94M | -47.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -114.12% | 8.3% |
| Return On Invested Capital | -92.91% | -330.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$3.93M | 36.4% |
| Operating Free Cash Flow | -$3.93M | 35.5% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.47 | 1.29 | 0.97 | 0.41 | -80.49% |
| Price to Tangible Book Value | 27.61 | 42.04 | 24.93 | 0.41 | -99.35% |
| Enterprise Value to EBITDA | -2.66 | -2.27 | -1.19 | 0.32 | -107.58% |
| Return on Equity | -242.0% | -154.4% | -174.7% | -165.6% | -8.25% |
| Total Debt | $5.47M | $5.03M | $4.27M | $3.12M | -47.13% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
